RESEARCH TRIANGLE PARK, NC--(Marketwire - September 23, 2008) - According to the recently
published report, "Investigator-Initiated Trials: Building Superior IIT
Capabilities," developed by pharmaceutical market research leader Cutting
Edge Information, more pharmaceutical companies are formalizing the
collection process for IIT proposals (IITPs)
(
www.investigatorinitiatedtrials.com). Methods may differ from company to
company, but the consensus is clear -- IITP collection procedures help
control a once chaotic process.
Establishing an efficient submission process is the first hurdle toward
creating guidelines for IITPs. Medical science liaisons (MSLs) and sales
reps remain the number one source of IITP submissions, because of their
frequent communication and close contact with physicians. However, not all
companies rely solely on MSLs to collect IITPs. Some have established
online submission systems, which have served to open the process to
physicians worldwide.
Effectively communicating IITP submission guidelines to both internal and
external parties serves to facilitate the collection and review process.
Many of the companies surveyed find it useful to make guidelines for IITP
submissions public on their company website. This practice has helped
reduce the number of proposals with incomplete information.
"Pharmaceutical companies are flooded with IITPs every year," says Eric
Bolesh, lead author of the report. "Creating a set of standard operating
procedures for the collection of IITPs helps everyone down the line. The
review process becomes much more efficient when proposals from many
different investigators are written in a uniform manner."
To offer a comprehensive look at the current state of IIT management,
"Investigator-Initiated Trials: Building Superior IIT Capabilities"
provides data benchmarks that will enable companies to improve their IIT
initiatives. Findings center on the following topics:
-- Companies' assessments of IIT performance and areas of improvement
-- Study proposal review and evaluation timelines
-- Budgets and funding
-- IIT program profiles
Surveyed respondents reveal difficulties in selecting viable study
opportunities, tracking studies, overseeing clinical trial management and
making use of study findings. Beyond identifying these obstacles, however,
companies provide creative solutions. Based on data and these insights,
the report authors recommend strategies to optimize IIT performance.
Download a complimentary online brochure of "Investigator-Initiated Trials:
Building Superior IIT Capabilities" or purchase the report at:
www.investigatorinitiatedtrials.com.
Contact Information: For questions about the report, please contact:
Eric Bolesh
919-433-0209